# Grupo Supervielle S.A.: financial statements, quarterly

SUPV · NYSE · CIK 1517399 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/supv.md) · [Financials](/companies/supv/financials.md) · [Filings](/companies/supv/filings.md) · [Insiders](/companies/supv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/supv/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-01-01) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [14.8](/filings/0001193125-19-144326.md) | [25.2](/filings/0001104659-20-054569.md) | [70.6](/filings/0001104659-21-059154.md) | [54.3](/filings/0001558370-22-006510.md) | [108](/filings/0001558370-23-006859.md) | [198](/filings/0001558370-24-005935.md) | [328](/filings/0001517399-25-000017.md) | [499](/filings/0001517399-25-000017.md) | [653](/filings/0001517399-25-000017.md) |
| Total assets | $bn | [100](/filings/0001193125-19-144326.md) | [208](/filings/0001104659-20-054569.md) | [218](/filings/0001104659-20-054569.md) | [202](/filings/0001104659-21-059154.md) | [376](/filings/0001558370-22-006510.md) | [760](/filings/0001558370-23-006859.md) | [2,166](/filings/0001558370-24-005935.md) | [4,482](/filings/0001517399-25-000017.md) | [4,506](/filings/0001517399-25-000017.md) |
| Total liabilities | $bn | [88.1](/filings/0001193125-19-144326.md) | [177](/filings/0001104659-20-054569.md) | [192](/filings/0001104659-20-054569.md) | [171](/filings/0001104659-21-059154.md) | [322](/filings/0001558370-22-006510.md) | [660](/filings/0001558370-23-006859.md) | [1,878](/filings/0001558370-24-005935.md) | [3,738](/filings/0001517399-25-000017.md) | [3,707](/filings/0001517399-25-000017.md) |
| Shareholders' equity | $bn | [18.5](/filings/0001104659-20-054569.md) | [20.1](/filings/0001193125-19-144326.md) | [26.1](/filings/0001104659-20-054569.md) | [31.9](/filings/0001104659-21-059154.md) | [53.8](/filings/0001558370-22-006510.md) | [100](/filings/0001558370-23-006859.md) | [287](/filings/0001558370-24-005935.md) | [743](/filings/0001517399-25-000017.md) | [798](/filings/0001517399-25-000017.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.